Organovo advances 3D biologic printing

11/20/2012 | MedCityNews.com

Organovo is developing 3D printing of tissues and organs for drug development as well as for therapeutic use. "I can tell you that we are progressing active research in the areas of liver, blood vessel, bone and cartilage, cardiac and kidney," said Michael Renard, the San Diego-based company's executive vice president of commercial operations.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC